Cellular and cytokine changes in the alveolar environment among immunocompromised patients during Pneumocystis jirovecii infection.
Limited data exist on the cytokine and cellular changes in the alveolar environment in immunocompromised patients during Pneumocystis jirovecii infection. A cellular and a cytokine analysis were performed on bronchoalveolar lavage (BAL) samples from three groups of patients, i.e., an initial study group of 64 immunocompromised P. jirovecii-positive individuals and two control groups of P. jirovecii-negative patients who had been or not immunosuppressed (65 patients). The results were related to alveolar dilution as determined by urea measurement. Compared with non-infected groups, P. jirovecii-infected patients had a lower level of alveolar macrophages (AM), particularly those with high burdens of P. jirovecii. Alveolar macrophages over-expressed the Dectin-1 receptor, which was largely implicated in P. jirovecii clearance. The alveolar CD8+T and CD4+T lymphocyte counts were increased and an inverse correlation was observed between the alveolar CD4+ cell count and the P. jirovecii burden. Although the alveolar IL-6 level was considerably increased, alveolar IL-17, IL-10, TNF-α, TGF-β concentrations of P. jirovecii patients were not different from the control groups. Changes in the pulmonary environment were also highlighted during P. jirovecii colonization. Our study suggests that there is a correlation between the P. jirovecii burden in the alveolus (from colonization to a high P. jirovecii burden), and the degree of impairment of the alveolar immune response.
Iriart
Xavier
X
Service de Parasitologie Mycologie, Centre Hospitalier Universitaire de Toulouse, H ô pital Rangueil, Toulouse, France. xabierlete@yahoo.fr
Witkowski
Benoit
B
Courtais
Caroline
C
Abbes
Sarah
S
Tkaczuk
Jean
J
Courtade
Monique
M
Cassaing
Sophie
S
Fillaux
Judith
J
Blancher
Antoine
A
Magnaval
Jean-François
JF
Pipy
Bernard
B
Berry
Antoine
A
D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D016207:Cytokines / Q000378:metabolism*; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D016867:Immunocompromised Host; D016676:Macrophages, Alveolar / Q000276:immunology; D008297:Male; D008875:Middle Aged; D045363:Pneumocystis carinii / Q000276:immunology / Q000472:pathogenicity*; D011020:Pneumonia, Pneumocystis / Q000276:immunology / Q000473:pathology*; D011650:Pulmonary Alveoli / Q000276:immunology / Q000382:microbiology / Q000473:pathology*
D016207:Cytokines